SledgeKey Learn
Backtesting Academy
Every term you encounter in a SledgeKey backtest, explained. Configuration parameters, performance metrics, risk measures, and the methodology that keeps results honest.
Configuration
Rebalance Frequency
How often the portfolio rescreens and resets weights. Quarterly, monthly, or annual, each with different cost and signal trade-offs.
Transaction Cost
The slippage and fees deducted on every trade. The single most underestimated drag on backtested returns.
Weighting Metric
How positions are sized — equal weight, market cap, revenue, or other fundamentals. Determines whether the strategy is concentrated or balanced.
Max Holdings
The maximum number of positions in the portfolio. Controls diversification and the dilution of your top picks.
Max Position Size
A cap on how much of the portfolio any single stock can occupy. Prevents concentration risk in cap-weighted portfolios.
Backtest Window
The historical period the strategy is tested over. Length, regime coverage, and where you start all matter.
Initial Capital
The starting balance of the simulated portfolio. Doesn't change percentage returns, but matters for absolute dollar metrics.
Benchmark Selection
The reference index that performance is compared against. SPY is the default, and choosing wisely matters more than people think.
Hedge Protection
An optional protective put overlay that triggers below a threshold. Costs premium in exchange for downside truncation.
Performance Metrics
Total Return
The cumulative percentage gain or loss over the backtest period. The headline number, but rarely the most useful one.
Annual Return (CAGR)
The constant annual rate that compounds to the same total return. The fairest single-number measure across windows of different lengths.
Sharpe Ratio
Excess return per unit of total volatility. The standard measure of risk-adjusted return.
Volatility
Annualized standard deviation of returns. The denominator of Sharpe and a proxy for risk.
Max Drawdown
The largest peak-to-trough decline. The pain metric, what it would have felt like to ride this strategy.
Win Rate
The percentage of months with positive returns. A measure of consistency, not magnitude.
Best & Worst Month
The single-month extremes. Helpful for sizing your stomach against the strategy.
Calendar Year Returns
Performance broken out year by year. Reveals whether returns came from one lucky window or showed up consistently.
Risk Metrics
Sortino Ratio
Sharpe's better-behaved cousin — divides excess return only by downside volatility, since upside surprises aren't risk.
Calmar Ratio
Annual return divided by max drawdown. Measures return per unit of pain rather than per unit of volatility.
Value at Risk (VaR 95%)
The 5th percentile of monthly returns. The threshold worse than 95% of months, useful for tail planning.
Conditional VaR (CVaR 95%)
The average return inside that worst 5% of months. Captures how bad it gets when it gets bad.
Coming Soon
Skewness
Whether the return distribution leans left or right. Negative skew means rare large losses, positive means rare large gains.
Coming Soon
Kurtosis
How fat the tails of the return distribution are. High kurtosis means more extreme months than a normal distribution would predict.
Coming Soon
Drawdown Episodes
The top five peak-to-trough declines with their dates, depths, and recovery durations. The full pain catalog.
Coming Soon
Rolling 12-Month Sharpe
Sharpe ratio computed over a moving 12-month window. Reveals whether risk-adjusted performance was stable or episodic.
Coming Soon
Rolling 12-Month Returns
Trailing-year return at every point in time. Shows the strategy's hit rate against a 1-year holding period.
Coming Soon
Methodology
What Is Backtesting?
Simulating a strategy on historical data to estimate how it would have performed. The promise, the pitfalls, and the framing.
Coming Soon
Survivorship Bias
When a backtest only includes companies that still exist today. Inflates returns by quietly excluding the failures.
Coming Soon
Look-Ahead Bias
Using data the strategy could not have known at the time. Subtle, common, and devastating to result credibility.
Coming Soon
Point-in-Time Data
Using the financial data exactly as it was reported on each historical date — restated values not allowed.
Coming Soon
Out-of-Sample Testing
Validating a strategy on data that wasn't used to design it. The single best defense against overfitting.
Coming Soon
Overfitting
Designing a strategy that worked in the past because it was tuned to the past. The cardinal sin of backtesting.
Coming Soon
Rebalancing Methodology
How a portfolio resets at each period — the discipline that separates a real strategy from a buy-and-forget portfolio.
Coming Soon
Risk-Free Rate
The return of holding short-term Treasuries. The opportunity cost embedded in every Sharpe and Sortino calculation.
Coming Soon
Hedging
Protective Puts
Buying put options to truncate downside. The mechanic, the cost, and why SledgeKey applies them at the portfolio level rather than per stock.
Coming Soon
Black-Scholes-Merton
The pricing model SledgeKey uses to value protective puts. How the inputs map to the cost you pay each rebalance.
Coming Soon
Treasury Rates as Risk-Free
Why short-term Treasuries are the proxy for the risk-free rate, and how SledgeKey uses live treasury data in its option pricing.
Coming Soon
Implied Volatility from Returns
How volatility is estimated for option pricing in a backtest, when there's no live options market to read it from.
Coming Soon